Insulin resistance and obesity: Resistin, a hormone secreted by adipose tissue

Nutrition Reviews

Volumn 62, Issue 10, 2004, Pages 389-394

  Wolf, George ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b International Life Sciences Institute   (United States)

Author keywords

Adipocyte secreted factor; Adipocytes; Peroxisome proliferator activated receptor ; Resistin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN;

ADIPOCYTE; ADIPOSE TISSUE; CELL DIFFERENTIATION; DIABETES MELLITUS; DISEASE MODEL; DRUG ACTIVITY; DRUG EFFECT; FOOD DEPRIVATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HORMONAL THERAPY; HUMAN; INSULIN RESISTANCE; INSULIN TREATMENT; LIPOGENESIS; NONHUMAN; OBESITY; REFEEDING; REVIEW;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS; HOMEOSTASIS; HORMONES, ECTOPIC; HUMANS; INSULIN RESISTANCE; OBESITY; RESISTIN;

EID: 4944251744     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2004.oct.389-394     Document Type: Review

References (20)

1. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-481.
2. Smas CM, Sul HS. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell. 1993;73:725-734.
3. Peraldi P, Spiegelman B. TNF-alpha and insulin resistance: summary and future prospects. Mol Cell Biochem. 1998;182:169-175.
4. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific factor inhibits adipocyte differentiation. J Biol Chem. 2001;276:11252-11256.
5. Steppan CM, Bailley ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312.
6. Holcomb IN, Kabakoff RC, Chan B, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 2000;19:4046-4055.
7. Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A. 2001;98:502-506.
8. Patel SD, Rajala MW, Rossetti L, Scherer PE, Shapiro L. Disulfide-dependent multimeric assembly of resistin family hormones. Science. 2004;304:1154-1158.
9. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest. 2003;111:225-230.
10. Way JM, Görgün CZ, Tong Q, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferators-activated receptor γ agonists. J Biol Chem. 2001;276:25651-25653.
11. Banerjee RR, Rangwala SM, Shapiro JS, et al. Regulation of fasted blood glucose by resistin. Science. 2004;303:1195-1198.
12. Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes. 2000;49:896-903.
13. Kim KH, Zhao L, Moon Y, Kang C, Sul HS. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Nat Acad Sci U S A. 2004;101:6780-6785.
14. Fehmann HC, Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res. 2002;34:671-673.
15. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin and adiposity in obese individuals. Obes Res. 2003;11:997-1001.
16. Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes. 2003;52:1611-1618.
17. De Courten BV, Degawa-Yamauchi M, Considine RV, Tataranni PA. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes. 2004;53:1279-1284.
18. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 2001;285:561-564.
19. Savage DB, Sewter CP, Klenk ES, et al. Resistin/FIZZ3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 2001;50:2199-2202.
20. Hotamisligil G. The irresistible biology of resistin. J Clin Invest. 2003;111:173-174.